Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease.
Saved in:
| Title: | Targeting endogenous kidney regeneration using anti-IL11 therapy in acute and chronic models of kidney disease. |
|---|---|
| Authors: | Widjaja AA; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore. anissa.widjaja@duke-nus.edu.sg., Viswanathan S; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Shekeran SG; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Adami E; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany., Lim WW; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore.; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore., Chothani S; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Tan J; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore., Goh JWT; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Chen HM; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Lim SY; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Boustany-Kari CM; Boehringer Ingelheim, CardioMetabolic Disease Research, Berlin, Germany., Hawkins J; Boehringer Ingelheim, CardioMetabolic Disease Research, Berlin, Germany., Petretto E; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Hübner N; Cardiovascular and Metabolic Sciences, Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site Berlin, 13347, Berlin, Germany.; Charité-Universitätsmedizin, 10117, Berlin, Germany., Schafer S; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Coffman TM; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore., Cook SA; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore, Singapore. stuart.cook@duke-nus.edu.sg.; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore, Singapore. stuart.cook@duke-nus.edu.sg.; MRC-London Institute of Medical Sciences, Hammersmith Hospital Campus, London, UK. stuart.cook@duke-nus.edu.sg. |
| Source: | Nature communications [Nat Commun] 2022 Dec 05; Vol. 13 (1), pp. 7497. Date of Electronic Publication: 2022 Dec 05. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-022-35306-1 |
